Neoadjuvant Chemotherapy and Ipilimumab For Stage II-IIIA Non-Small Cell Lung Cancer
Objective of this Therapy Area Insight Immune therapy is increasingly becoming an effective treatment for non-small cell lung cancer (NSCLC). The Objective of this study is to determine the percentage of early stage NSCLC patients with detectable circulating T cells specific against tumor-associated antigen (TAA) after receiving platinum based neoadjuvant chemotherapy plus ipilimumab before surgery.…
What Doctors Expect from an Impactful Webinar
Companies worldwide have accelerated their digital transformation by adopting webinars in a big way for HCP engagement. The challenge however is that almost every player is doing it.Can Pharma marketers create impact in a crowded webinar space? The answer is to differentiate well and execute effectively.
